- Home
- ONT vs MDXG Comparison
ONT vs MDXG Comparison
Compare ONT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONT | MDXG |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | 3500 | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 643.7M | 625.6M |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ONT | MDXG |
|---|---|---|
| Price | $18.10 | $4.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 503.4K | ★ 935.2K |
| Earning Date | N/A | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 93.69 | 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $830,538,000.00 | $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 19.26 | ★ 19.99 |
| 52 Week Low | $12.68 | $3.03 |
| 52 Week High | $23.32 | $7.97 |
Technical Indicators
Market Signals| Indicator | ONT | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 64.62 |
| Support Level | $14.39 | $4.11 |
| Resistance Level | $18.32 | $4.76 |
| Average True Range (ATR) | 0.84 | 0.18 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 60.04 | 91.11 |
Price Performance
Historical ComparisonAbout ONT Onterris Inc. Common Stock
Onterris Inc is an environmental solutions company. The company provides environmental solutions to organizations addressing regulatory, operational, and environmental challenges. Its services include the application of scientific, engineering, and data-driven approaches to support risk management, compliance, and environmental protection, including air, water, and soil.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.